Gould Asset Management »

Iovance Biotherapeutics shares owned by Gould Asset Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Gould Asset Management from 13F filings

Historical chart of Gould Asset Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Gould Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Gould Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $26k 12k 2.17
2025-06-30 $20k 12k 1.72
2025-03-31 $39k 12k 3.33

More positions owned by Gould Asset Management

S&p 500 Depository Receipt Tr Unit (SPY)
Vanguard Short Term Treasury Short Term Treas (VGSH)
Ishares 0-5 Year Tips Bond Et 0-5 Yr Tips Etf (STIP)
Ishares Barclays 20 Year Tre 20 Yr Tr Bd Etf (TLT)
Vanguard Short-term Corporate Shrt Trm Corp Bd (VCSH)
Invesco Taxable Municipal Bon Taxable Mun Bd (BAB)
Ishares S&p 500 Index Etf Core S&p500 Etf (IVV)
Spdr Gold Minishares Trust Spdr Gld Minis (GLDM)
Vanguard Reit Index Etf Real Estate Etf (VNQ)
Spdr Barclays Intl Treasury B Bloomberg Intl T (BWX)
Vanguard Ftse Developed Marke Van Ftse Dev Mkt (VEA)
Spdr S&p 500 Fossil Fuel Rese Spdr S&p 500 Etf (SPYX)
Apple (AAPL)
Pimcototal Return Etf Active Bd Etf (BOND)
Wisdomtree Emmkts Ex-stt-ownd Em Ex St-owned (XSOE)

View all positions for Gould Asset Management

Top funds holding Iovance Biotherapeutics

MHR Fund Management
BlackRock
Vanguard Group
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Morgan Stanley
Susquehanna International
Citadel Advisors
Millennium Management
Principal Financial Group
Dimensional Fund Advisors

View all funds holding Iovance Biotherapeutics